Perianal Fistulae in Crohn's Disease: Current and Future Approaches to Treatment

被引:27
作者
Keshaw, Hussila [1 ]
Foong, Keen S. [1 ]
Forbes, Alastair [1 ]
Day, Richard M. [1 ]
机构
[1] UCL, Windeyer Inst, Biomat & Tissue Engn Grp, Ctr Gastroenterol & Nutr, London W1T 4JF, England
基金
英国医学研究理事会;
关键词
Crohn's disease; perianal fistula; therapy; biomaterials; TUMOR-NECROSIS-FACTOR; HIGH ANAL FISTULAS; ENDORECTAL ADVANCEMENT FLAP; RANDOMIZED CONTROLLED-TRIAL; INFLAMMATORY-BOWEL-DISEASE; SMALL-INTESTINAL SUBMUCOSA; MONOCLONAL-ANTIBODY CA2; TERM-FOLLOW-UP; FIBRIN GLUE; IN-ANO;
D O I
10.1002/ibd.21137
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Perianal fistulae are common in Crohn's disease but rarely heal without treatment. The main aim of treatment is to effectively close the fistula without affecting sphincter integrity and continence. Traditional surgical and medical approaches are not without their limitations and may result in either comorbidity, such as fecal incontinence, or incomplete healing of the fistulae. Over the last 2 decades these limitations have led to a paradigm shift toward the use of biomaterials. and more recently cell-based therapies, which have met with variable degrees of success. This review discusses the traditional and current methods of treatment, as well as emerging and possible alternative approaches that may improve fistula healing.
引用
收藏
页码:870 / 880
页数:11
相关论文
共 143 条
[1]
Bioglue for the treatment of anal fistula is associated with acute anal sepsis [J].
Abbas, Maher A. ;
Tejirian, Talar .
DISEASES OF THE COLON & RECTUM, 2008, 51 (07) :1155-1155
[2]
AUTOLOGOUS FIBRIN GLUE IN THE TREATMENT OF RECTOVAGINAL AND COMPLEX FISTULAS [J].
ABEL, ME ;
CHIU, YSY ;
RUSSELL, TR ;
VOLPE, PA .
DISEASES OF THE COLON & RECTUM, 1993, 36 (05) :447-449
[3]
Risk for active tuberculosis in inflammatory bowel disease patients [J].
Aberra, Faten N. ;
Stettler, Nicolas ;
Brensinger, Colleen ;
Lichtenstein, Gary R. ;
Lewis, James D. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (09) :1070-1075
[4]
AHMAD NM, 2007, J INFECTION, V54, P29
[5]
Aitola P, 1999, ANN CHIR GYNAECOL FE, V88, P136
[6]
Obliteration of the fistulous tract with BioGlue® adversely affects the outcome of transanal advancement flap repair [J].
Alexander, S. M. ;
Mitalas, L. E. ;
Gosselink, M. P. ;
Oom, D. M. J. ;
Zimmerman, D. D. E. ;
Schouten, W. R. .
TECHNIQUES IN COLOPROCTOLOGY, 2008, 12 (03) :225-228
[7]
Perianal fistulae following infliximab treatment - Clinical and endosonographic outcome [J].
Ardizzone, S ;
Maconi, G ;
Colombo, E ;
Manzionna, G ;
Bollani, S ;
Porro, GB .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (02) :91-96
[8]
Autologous fibroblasts transplant after infliximab administration: a new approach in Crohn's perianal fistulas? Brief clinical report [J].
Ascanelli, S. ;
de Tullio, D. ;
Gregorio, C. ;
Azzena, G. ;
Occhionorelli, S. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (09) :1135-1136
[9]
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[10]
Biological in vitro effects of fibrin glue: Fibroblast proliferation, expression and binding of growth factors [J].
Becker, JC ;
Domschke, W ;
Pohle, T .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (10) :927-932